Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Sumatriptan + Naproxen
Suvexx
Not routinely available
SMC
23/07/2025

Indication

The acute treatment of the headache phase of migraine attacks with or without aura in adults where treatment with a mono-entity product has been insufficient.

The acute treatment of the headache phase of migraine attacks with or without aura in adults where treatment with a mono-entity product has been insufficient.

Therapeutic Area

Central nervous system

Status Description

Not routinely available as not recommended for use in NHSScotland

Formulation

Sumatriptan 85mg / Naproxen 457mg

Comments

Link to Advice

Advice Published

09/06/2025

SMC Submission Type

Abbreviated

SMC Status

Not recommended